您当前的位置：
首页 >
文章列表页 >
Development of an orally bioavailable selective inhibitor of the menin-MLL
Short communication | 更新时间：2023-08-29

    • Development of an orally bioavailable selective inhibitor of the menin-MLL

    • Genes & Diseases   Vol. 10, Issue 5, (2023)
    • 作者机构：

      1. Department of Pharmacology, Yale University School of Medicine,CT,New Haven,USA,06520

      2. Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau,Macao SAR,China

      3. Department of Chemistry, Hong Kong Baptist University, Kowloon Tong,Hong Kong SAR,China

      4. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau,Macao SAR,China

      5. International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University,Guangdong,Guangzhou,China,510632

    • DOI：10.1016/j.gendis.2022.10.005    

      CLC：

    • Published：2023，

      Published Online：1 September 2023，

    扫 描 看 全 文

  • Hai-Jing Zhong, Wanhe Wang, Wei Zhou, et al. Development of an orally bioavailable selective inhibitor of the menin-MLL. [J]. Genes & Diseases 10(5).(2023) DOI： 10.1016/j.gendis.2022.10.005.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0